REMAP-CAP Study: Rationale and Design

Here is the link that Berry Consultants and the international REMAP-CAP team describe the Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) study in a manuscript published in the Annals of the American Thoracic Society (AnnalsATS).

More Recent News

July 2024 FACTS Webinar

The Berry Consultants software team will be presenting the open enrollment option in the FACTS Dose Escalation N-CRM (Bayesian Logistic Regression) module.

June 2024 FACTS Webinar

The FACTS software team will be presenting an early look at the new features of the upcoming FACTS 7.1 release.